Showing 21 - 40 results of 41,877 for search '(((( i values decrease ) OR ( ((i large) OR (a large)) decrease ))) OR ( b large increased ))', query time: 1.79s Refine Results
  1. 21
  2. 22

    Temporal trends in large carnivore attacks on humans in different regions of the world. by Giulia Bombieri (8613945)

    Published 2023
    “…<p>(<b>A</b>) The number of attacks shows a nonlinear increase over the years, as evidenced by fitting the general additive mixed model of the number of attacks-1 as a function of the smoothing factor “year.” …”
  3. 23
  4. 24

    ECoG timescales decrease during spatial attention. by Isabel Raposo (21615517)

    Published 2025
    “…If power was above the threshold (<i>z</i> > 1.96) for a minimum of 10% of the time window (500 ms) after the cue, the channel was considered hemifield-selective. …”
  5. 25
  6. 26
  7. 27
  8. 28

    Table4_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX by Cong Xu (203537)

    Published 2022
    “…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …”
  9. 29

    Table3_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX by Cong Xu (203537)

    Published 2022
    “…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …”
  10. 30

    Table6_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX by Cong Xu (203537)

    Published 2022
    “…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …”
  11. 31

    Table2_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX by Cong Xu (203537)

    Published 2022
    “…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …”
  12. 32

    Table5_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX by Cong Xu (203537)

    Published 2022
    “…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …”
  13. 33
  14. 34

    The transcriptional response of IECs to <i>C</i>. <i>albicans</i> infection is largely damage- and filamentation-independent. by Jakob L. Sprague (18087148)

    Published 2024
    “…(C) Significantly differentially expressed genes between <i>ece1</i>Δ/Δ and <i>efg1</i>ΔΔ/<i>cph1</i>ΔΔ <i>C</i>. …”
  15. 35

    Seven out of the 11 human cytidine deaminases are more highly expressed in tumor versus normal tissue and their higher expression is correlated with a decrease in survival. by Mason A. McCool (11889842)

    Published 2024
    “…Data were analyzed by Kaplan–Meier survival analysis, significant <i>p</i>-values reported on respective graphs. (B) Seven out of the 11 human cytidine deaminases exhibit higher expression in tumor versus normal tissue and higher expression is associated with lower survival probability. …”
  16. 36
  17. 37
  18. 38
  19. 39
  20. 40